M. J. Broekman

发表

Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39.

M. Hyman, D. Petrović-Djergović, S. Visovatti, 2009, The Journal of clinical investigation.

Optical Projection Tomography as a Tool for 3D Microscopy and Gene Expression Studies

J. Vane, S. Moncada, M. J. Broekman, 2002 .

M. J. Broekman, A. Marcus, D. Pinsky, 2002, The New England journal of medicine.

Calreticulin, an Antithrombotic Agent Which Binds to Vitamin K-dependent Coagulation Factors, Stimulates Endothelial Nitric Oxide Production, and Limits Thrombosis in Canine Coronary Arteries (*)

M. J. Broekman, A. Marcus, D. Pinsky, 1995, The Journal of Biological Chemistry.

P2X(1) receptor inhibition and soluble CD39 administration as novel approaches to widen the cardiovascular therapeutic window.

M. J. Broekman, A. Marcus, M. Mahaut-Smith, 2009, Trends in cardiovascular medicine.

Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization.

S. Rafii, D. Jin, M. J. Broekman, 2006, The Journal of clinical investigation.

Platelet-erythrocyte interactions enhance alpha(IIb)beta(3) integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivo.

M. J. Broekman, A. Marcus, J. Aznar, 2002, Blood.

Targeted Deletion of Ectonucleoside Triphosphate Diphosphohydrolase 1/CD39 Leads to Desensitization of Pre- and Postsynaptic Purinergic P2 Receptors

M. J. Broekman, A. Marcus, R. Levi, 2007, Journal of Pharmacology and Experimental Therapeutics.

Aspirin therapy for inhibition of platelet reactivity in the presence of erythrocytes in patients with vascular disease.

M. J. Broekman, A. Marcus, J. Aznar, 2006, The Journal of laboratory and clinical medicine.

Cell-type specificity of ectonucleotidase expression and upregulation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

M. J. Broekman, A. Marcus, Joshua I. Park, 2002, Archives of biochemistry and biophysics.

Role of extracellular ATP metabolism in regulation of platelet reactivity.

M. J. Broekman, A. Marcus, H. Szeto, 2002, The Journal of laboratory and clinical medicine.

Role of a novel soluble nucleotide phospho-hydrolase from sheep plasma in inhibition of platelet reactivity: hemostasis, thrombosis, and vascular biology.

M. J. Broekman, A. Marcus, H. Szeto, 2002, The Journal of laboratory and clinical medicine.

CD39/NTPDase-1 activity and expression in normal leukocytes.

M. J. Broekman, A. Marcus, J. Kizer, 2007, Thrombosis research.

Ectonucleotidase in Sympathetic Nerve Endings Modulates ATP and Norepinephrine Exocytosis in Myocardial Ischemia

M. J. Broekman, A. Marcus, R. Levi, 2003, Journal of Pharmacology and Experimental Therapeutics.

CD39 ecto‐ADPase

M. J. Broekman, A. Marcus, D. Pinsky, 2002 .

Platelet-erythrocyte interactions enhance IIb 3 integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivo

M. J. Broekman, A. Marcus, J. Aznar, 2002 .

Feedback Regulation of Endothelial Cell Surface Plasmin Generation by PKC-dependent Phosphorylation of Annexin A2*

Bihui Huang, M. J. Broekman, A. Marcus, 2010, The Journal of Biological Chemistry.

platelet eicosanoid metabolism toward 12 ( S )-hyd roxyeicosatet raenoic acid '

M. J. Broekman, A. Marcus, A. Eiroa, 2002 .

Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain.

Yuan Zhang, E. Connolly, Judy Huang, 2002, The Journal of clinical investigation.

EctoNucleotidase in cardiac sympathetic nerve endings modulates ATP-mediated feedback of norepinephrine release.

M. J. Broekman, A. Marcus, R. Levi, 2002, The Journal of pharmacology and experimental therapeutics.

CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia.

M. J. Broekman, A. Marcus, J. Kizer, 2011, Clinical lymphoma, myeloma & leukemia.

Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis.

Jonathan D. Smith, M. J. Broekman, A. Marcus, 2009, The Journal of clinical investigation.

Role of CD39 (NTPDase-1) in Thromboregulation, Cerebroprotection, and Cardioprotection

M. J. Broekman, A. Marcus, D. Pinsky, 2005, Seminars in thrombosis and hemostasis.

CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia

M. J. Broekman, A. Marcus, R. Furman, 2007, Journal of Translational Medicine.

Metabolic Control of Excessive Extracellular Nucleotide Accumulation by CD39/Ecto-Nucleotidase-1: Implications for Ischemic Vascular Diseases

M. J. Broekman, A. Marcus, D. Pinsky, 2003, Journal of Pharmacology and Experimental Therapeutics.

Optimizing human apyrase to treat arterial thrombosis and limit reperfusion injury without increasing bleeding risk

M. J. Broekman, A. Marcus, S. Robson, 2014, Science Translational Medicine.

Effects of SolCD39, a Novel Inhibitor of Platelet Aggregation, on Platelet Deposition and Aggregation after PTCA in a Porcine Model

M. J. Broekman, A. Marcus, N. Kleiman, 2005, Journal of Thrombosis and Thrombolysis.

Ectonucleoside Triphosphate Diphosphohydrolase1/CD39, Localized in Neurons of Human and Porcine Heart, Modulates ATP-Induced Norepinephrine Exocytosis

M. J. Broekman, A. Marcus, P. Heerdt, 2005, Journal of Pharmacology and Experimental Therapeutics.

The ratio of ADP- to ATP-ectonucleotidase activity is reduced in patients with coronary artery disease.

M. J. Broekman, A. Marcus, S. Sedlis, 2005, Thrombosis research.

CD39/NTPDase1 Variants Identified in Human Neutrophils Regulate Antithrombotic Activity.

M. J. Broekman, A. Marcus, J. Drosopoulos, 2005 .